Investment
Features
FeesSafety
Academy
More
Pluang+

Compare REX AI Equity Premium Income ETF (AIPI) vs Amphastar Pharmaceuticals Inc (AMPH) Price & Performance

REX AI Equity Premium Income ETFTrade
Amphastar Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

REX AI Equity Premium Income ETF vs Amphastar Pharmaceuticals Inc — how do they compare? REX AI Equity Premium Income ETF trades at $37.66, while Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M). The key difference: REX AI Equity Premium Income ETF is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

AIPIAMPH
Sector
Income / Options OverlayHealth
52-Week High
$44.93$30.81
52-Week Low
$32.45$16.87
Market Cap
$868.62M
Enterprise Value
$1.27B

Returns comparison

Trailing returns across standard periods

About REX AI Equity Premium Income ETF

AIPI provides exposure to leading artificial intelligence firms while seeking to generate monthly income. It uses a covered call strategy to capture premiums from the volatility of AI-related stocks.

Read more on AIPI

About Amphastar Pharmaceuticals Inc

Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.

Read more on AMPH